Bulk Manufacturer of Controlled Substances Application: Siemens Healthcare Diagnostics Inc., 3197 [2021-00648]

Download as PDF 3197 Federal Register / Vol. 86, No. 9 / Thursday, January 14, 2021 / Notices including the validity of the methodology and assumptions used; —Evaluate whether and if so how the quality, utility, and clarity of the information to be collected can be enhanced; and —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. khammond on DSKJM1Z7X2PROD with NOTICES Overview of This Information Collection 1. Type of Information Collection (check justification or form 83): Extension with change of a currently approved collection. 2. The Title of the Form/Collection: Records and Supporting Data: Importation, Receipt, Storage, and Disposition by Explosives Importers, Manufacturers, Dealers, and Users Licensed Under Title 18 U.S.C. Chapter 40 Explosives. 3. The agency form number, if any, and the applicable component of the Department sponsoring the collection: Form number (if applicable): None. Component: Bureau of Alcohol, Tobacco, Firearms and Explosives, U.S. Department of Justice. 4. Affected public who will be asked or required to respond, as well as a brief abstract: Primary: Business or other for-profit. Other (if applicable): None. Abstract: This information collection requires the maintenance of records showing daily activities in the importation, manufacture, receipt, storage, and disposition of all explosive materials covered under 18 U.S.C. Chapter 40 Explosives. These records must also show where and to whom explosive materials are sent, thereby ensuring that any diversions will be readily apparent, and that ATF will be immediately notified if these materials are lost or stolen. 5. An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: An estimated 9,411 respondents will prepare records for this information collection annually, and it will take each respondent approximately 12.6 hours to prepare the required records. 6. An estimate of the total public burden (in hours) associated with the collection: The estimated annual public burden associated with this collection is 592,893 hours, which is equal to 47,055 VerDate Sep<11>2014 03:30 Jan 14, 2021 Jkt 253001 (# of annual responses) * 12.6 (# of hours per response). 7. An Explanation of the Change in Estimates: The adjustments associated with this collection include a decrease in the number of respondents, responses and total burden hours by 516, 2,580, and 32,508 hours respectively, since the last IC renewal in 2017. If additional information is required contact: Melody Braswell, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Two Constitution Square, 145 N Street NE, 3E.405A, Washington, DC 20530. following basic class of controlled substance: Controlled substance Ecgonine ....................... Drug code 9180 Schedule II The company plans to produce the listed controlled substance in bulk to be used in the manufacture of DEA exempt products. No other activities for these drug codes are authorized for this registration. William T. McDermott, Assistant Administrator. [FR Doc. 2021–00648 Filed 1–13–21; 8:45 am] Dated: January 11, 2021. Melody Braswell, Department Clearance Officer for PRA, U.S. Department of Justice. BILLING CODE P [FR Doc. 2021–00743 Filed 1–13–21; 8:45 am] Drug Enforcement Administration BILLING CODE 4410–02–P [Docket No. DEA–766] DEPARTMENT OF JUSTICE Drug Enforcement Administration Bulk Manufacturer of Controlled Substances Application: Siemens Healthcare Diagnostics Inc. Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: Siemens Healthcare Diagnostics Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before March 15, 2021. Such persons may also file a written request for a hearing on the application on or before March 15, 2021. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUMMARY: In accordance with 21 CFR 1301.33(a), this is notice that on December 11, 2020, Siemens Healthcare Diagnostics Inc., 100 GBC Drive, Mailstop 514, Newark, Delaware 19702–2461, applied to be registered as a bulk manufacturer of the SUPPLEMENTARY INFORMATION: Frm 00089 Fmt 4703 Bulk Manufacturer of Controlled Substances Application: IsoSciences, LLC Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: [Docket No. DEA–768] PO 00000 DEPARTMENT OF JUSTICE Sfmt 4703 IsoSciences, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTAL INFORMATION listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before March 15, 2021. Such persons may also file a written request for a hearing on the application on or before March 15, 2021. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this is notice that on November 11, 2020, IsoSciences, LLC, 340 Mathers Road, Ambler, Pennsylvania 19002–3420, applied to be registered as an bulk manufacturer of the following basic class(es) of controlled substance(s): SUMMARY: Controlled substance Cathinone ................................ Methcathinone ........................ Lysergic acid diethylamide ..... Marihuana ............................... E:\FR\FM\14JAN1.SGM 14JAN1 Drug code 1235 1237 7315 7360 Schedule I I I I

Agencies

[Federal Register Volume 86, Number 9 (Thursday, January 14, 2021)]
[Notices]
[Page 3197]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-00648]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-768]


Bulk Manufacturer of Controlled Substances Application: Siemens 
Healthcare Diagnostics Inc.

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Siemens Healthcare Diagnostics Inc. has applied to be 
registered as a bulk manufacturer of basic class(es) of controlled 
substance(s). Refer to Supplemental Information listed below for 
further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before March 15, 2021. 
Such persons may also file a written request for a hearing on the 
application on or before March 15, 2021.

ADDRESSES:  Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on December 11, 2020, Siemens Healthcare Diagnostics 
Inc., 100 GBC Drive, Mailstop 514, Newark, Delaware 19702-2461, applied 
to be registered as a bulk manufacturer of the following basic class of 
controlled substance:

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Ecgonine...............................     9180  II
------------------------------------------------------------------------

    The company plans to produce the listed controlled substance in 
bulk to be used in the manufacture of DEA exempt products. No other 
activities for these drug codes are authorized for this registration.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-00648 Filed 1-13-21; 8:45 am]
BILLING CODE P